Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations-Reference-Cited by-同舟云学术

Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations

Published:2018-11 Issue:5 Volume:142 Page:1665-1669
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Forbes Lisa R.,Vogel Tiphanie P.,Cooper Megan A.,Castro-Wagner Johana,Schussler Edith,Weinacht Katja G.,Plant Ashley S.,Su Helen C.,Allenspach Eric J.,Slatter Mary,Abinun Mario,Lilic Desa,Cunningham-Rundles Charlotte,Eckstein Olive,Olbrich Peter,Guillerman R. Paul,Patel Niraj C.,Demirdag Yesim Y.,Zerbe Christa,Freeman Alexandra F.,Holland Steven M.,Szabolcs Paul,Gennery Andrew,Torgerson Troy R.,Milner Joshua D.,Leiding Jennifer W.

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference9 articles.

1. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype;Toubiana;Blood,2016

2. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations;Vargas-Hernandez;J Allergy Clin Immunol,2018

3. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease;Flanagan;Nat Genet,2014

4. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations;Milner;Blood,2015

5. A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea;Verstovsek;Cancer,2014

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure;Journal of Allergy and Clinical Immunology: Global;2024-11

2. Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations;Journal of Clinical Immunology;2024-08-23

3. JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review;Frontiers in Immunology;2024-08-23

4. TH2-driven manifestations of inborn errors of immunity;Journal of Allergy and Clinical Immunology;2024-08

5. Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks;Infection, Genetics and Evolution;2024-08